1. The Field of the Invention
The present invention relates generally to the post-surgical treatment of closed wounds and specifically to methods and systems for infusion of a wound site to manage pain, swelling, bleeding and infection.
2. The Relevant Technology
One of the most difficult aspects of enduring a major surgical procedure is coping with the post-operative pain and swelling. Commonly, opioid analgesics, sometimes referred to as narcotics, are administered post-operatively to counter the pain associated with wound healing and recovery. However, the use of systemic opioid analgesics, whether administered by oral, intramuscular, or intravenous methods, includes a host of possible undesirable side effects, including: respiratory depression, renal function depression, nausea, constipation, ataxia, confusion, sweating, and itching. The length of hospital stay for patients undergoing a major surgical procedure is, in part, determined by the need to monitor and control the side effects of systemically administered opioid analgesics.
More recently, infusion pumps have been used to percutaneously deliver local anesthetics directly to the surgical wound. Thus, many of the undesirable side effects of systemic opioid analgesics are avoided. Furthermore, medication dosage is considerably less than systemic delivery since the medication is delivered directly to the affected site. However, contemporary percutaneous pain medication infusion pumps do not provide consistent relief of pain. Furthermore, many currently available medication infusion pumping arrangements are unable to adequately aspirate the affected site to reduce fluid build-up and swelling.
Yet further, many medication infusion pumps are somewhat complex and/or difficult to assemble. Some such pumps may not have a mechanism by which the infusion reservoir can be sufficiently secured to the pump. Furthermore, a single controller is typically usable with only one type of reservoir module. Due to the lack of interchangeability among controllers and medication reservoir modules, a medical professional may need to choose between multiple controllers, depending on factors such as whether aspiration is needed. Accordingly, the process assembling and operating a medication infusion pumping arrangement is somewhat more complicated than is desirable.
Various embodiments of the present invention will now be discussed with reference to the appended drawings. It is appreciated that these drawings depict only typical embodiments of the invention and are therefore not to be considered limiting of its scope.
Referring to
In the embodiment of
As illustrated, the infusion catheter 16 has a proximal end 22 and a distal end 24, with a plurality of flow orifices 26 arrayed along the distal end 24 to provide infusion of medication along a relatively broad dispersal path within the internal wound site 12. Similarly, the aspiration catheter 18 has a proximal end 28 and a distal end 30, with a plurality of flow orifices 32 arranged along the distal end 30 to receive fluids from a relatively broad area of the internal wound site 12. The proximal end 22 of the infusion catheter 16 is generally nested within the proximal end 28 of the aspiration catheter 18 so that medication moves toward the internal wound site 12 through the infusion catheter 16, and fluids are removed from the internal wound site 12 through the distal end 30 of the aspiration catheter 18, and then through the generally annular space between the proximal ends 22, 28 of the catheters 16, 18.
Referring to
The controller 46 has a main body 52 that contains most of the internal components (not shown) of the controller 46, and a cap 54 that can be removed to couple the controller 46 to the reservoir module 48 in a manner that will be shown and described in greater detail subsequently. The main body 52 has a first portion 56 and a second portion 58 that are attached together via relative motion in the longitudinal direction 40 to encase the internal components, as will also be shown and described in greater detail. The controller 46 has controls such as buttons 60 that can be used by medical personnel to control the operation of the controller 46. Additionally, the controller 46 may have a display 62 that may show information such as infusion and aspiration history, the current operational mode of the controller 46, and the like.
The reservoir module 48 has a reservoir retainer 64 that serves to retain a first reservoir (not shown in
The reservoir retainer 64 has a first portion 68 and a second portion 70 that are attached together along the longitudinal direction 40 in a manner similar to that of the first and second portions 56, 58 of the main body 52 of the controller 46. Additionally, the reservoir module 48 has an infusion port 72 shaped to be connected to the proximal end 22 of the infusion catheter 16 and an aspiration port 74 shaped to be connected to the proximal end 28 of the aspiration catheter 18. A fill port 76 is shaped to be connected to a supply of medication to enable the first reservoir to be filled without removing it from the reservoir retainer 64.
The controller 46 and the reservoir module 48 are coupled together in a manner that is simple and relatively failsafe. The manner in which the controller 46 and reservoir module 48 are coupled together will be shown and described in greater detail with reference to
Referring to
The controller 46 has a pump 82, which may take the form of a peristaltic pump designed to compress a portion of the tube 80 and to move the compressed portion along the tube 80 to urge the medication to move through the tube 80 in a highly controllable manner. The pump 82 may include a plurality of rotors 84 retained by a rotor carriage 86 that rotates about an axis of rotation 88 to move the rotors 84 along a circular path. The rotor carriage 86 is driven by a motor (not shown in
The present invention envisions the use of a wide variety of different types of pumps. For example, peristaltic pumps need not involve stretching of a conduit about the rotors, but may instead be based upon compression of the conduit by the rotors against an opposing surface, such as a generally cylindrical interior wall. Indeed, a controller according to the present invention need not have a peristaltic pump, but may instead use a different type of pump such as a screw pump, a rotary vane pump, a rod-and-piston pump, or any other known type of pump.
The controller 46 also has a constraining member in the form of an arcuate wall 90 that abuts a portion of the tube 80 to control the path of the tube 80 around the rotors 84. The arcuate wall 90 also causes the tube 80 to assume a generally oval cross section proximate the arcuate wall to enhance the operation of a blockage sensor 92. The blockage sensor 92 is designed to sense preferential distention of the portion of the tube 80 proximate the arcuate wall 90 to determine whether the tube 80 or the infusion catheter 16 has been pinched or blocked. Accordingly, the blockage sensor 92 includes a switch 94 that either closes or opens a circuit in response to abnormal distention of the tube 80. Closing or opening the circuit may trigger cessation of infusion and/or aspiration, production of an audible alarm tone, or the like.
The cap 54 is generally shaped to cover the tube 80, the rotors 84, and the rotor carriage 86 to prevent external objects from interfering with the operation of the pump 82. The cap 54 has an alcove 96 shaped to adjoin the infusion and aspiration ports 72, 74 such that the infusion and aspiration ports 72, 74 are able to extend through the space covered by the cap 54. The cap 54 also has a locking tab 98, which may snap into engagement with the main body 52 of the controller 46 to keep the cap attached to the main body 52 until a threshold removal force is applied. The cap 54 also has a release tab 100 that may be pressed by a finger or thumb to facilitate removal of the cap 54 from the main body 52.
The controller 46 and the reservoir module 48 are easily attachable to each other. The controller 46 has a mating surface 102, and the reservoir module 48 has a mating surface 104 with a shape complementary to that of the mating surface 102 of the controller 46. The mating surfaces 102, 104 each extend along the longitudinal direction 40, or more precisely, the mating surfaces 102, 104 extend generally within planes perpendicular to the lateral direction 42. The mating surfaces 102, 104 are shaped such that they can be attached together via relative motion along an attachment direction 106 that extends along the longitudinal direction 40. The attachment direction 106 also extends substantially parallel to the axis of rotation 88 of the rotor carriage 86 and the motor that drives the pump 82. In this phrase, “substantially parallel” does not require precise parallelism, but rather encompasses objects that are angularly offset from each other by as much as 10°, or perhaps even more.
In this application, the term “mate” refers to any process by which two objects are rigidly, but not necessarily inseparably, coupled together. The phrase “mating surface” broadly refers to any surface designed to retain another surface. Although the mating surfaces 102, 104 are generally planar, alternative embodiments may include mating surfaces with a variety of shapes. A mating surface also need not provide for a large area of contact between mating parts, but may instead have one or more relatively small points of attachment. A “generally planar shape” includes surfaces with features that do not protrude excessively. Accordingly, a surface with a dovetail formed therein may have a generally planar shape.
In the embodiment of
Returning to the embodiment of
The central plateau 112 has two flared edges 116, only one of which is visible in
The central plateau 112 and the central recess 114 may be shaped such that the reservoir module 48 can only slide into engagement with the controller 46 from along one direction, i.e., from the relative position illustrated in
Accordingly, as the central plateau 112 slides along the longitudinal direction 40 into the central recess 114, the clearance between the flared edges 116 of the central plateau 112 and the flared edges 118 of the central recess 114 decreases gradually so that the dovetail features 108, 110 fit relatively snugly together when the controller 46 and the reservoir module 48 are longitudinally aligned as shown in
Additionally, the mating surfaces 102, 104 may have locking features that cause the mating surfaces 102, 104 to snap into engagement with each other when the relative positioning of
Referring to
As shown, the first portion 56 of the main body 52 has an alcove 130 shaped to fit around the display 62 of the controller. Similarly, the second portion 58 of the main body 52 has a pair of holes 132 through which the buttons 60 are able to protrude. The second portion 58 also has a battery cover 134 that is detachable to provide access to a plurality of batteries 136 that supply electrical power to the controller 46. The first and second portions 56, 58 generally contain a circuit board 138 on which a variety of electrical components may be mounted.
A motor 140 adjacent to the circuit board 138 drives the pump 82 by rotating the rotor carriage 86 about the axis of rotation 88 (shown in
In addition to the motor 140, the controller 46 may also contain a solenoid unit 142 positioned adjacent to the motor 140. The solenoid unit 142 controls the flow of fluid into the second reservoir 66, thereby controlling aspiration of fluids from the internal wound site 12. The operation of the solenoid unit 142 will be set forth in greater detail subsequently.
As embodied in
The first portion 68 of the reservoir retainer 64 has a first cavity (not visible in
The second portion 70 of the reservoir retainer 64 has a first cavity 152 and a second cavity 154. The second cavity 154 of the second portion 70 cooperates with the second cavity 150 of the first portion 68 to receive the second reservoir 66. The first cavity 152 of the second portion 70 cooperates with the first cavity of the first portion 68 to receive a first reservoir 156 that holds the medication to be infused into the internal wound site 12. Either of the first and second reservoirs 156, 66 may optionally be removable from the reservoir retainer 64 via relative motion in the longitudinal direction 40.
In addition to the tube 80, the reservoir module 48 has an aspiration conduit, which may take the form of a tube 158 that extends generally along the longitudinal direction 40. The tube 158 may be generally embedded within the first and second portions 68, 70 of the reservoir retainer 64, and may lead from the aspiration port 74 to the second reservoir 66. The tube 158 may be accessible through a slot 160 formed in the first and second portions 68, 70. Thus, the solenoid unit 142 may apply pressure to the tube 158 through the slot 160 to at least partially block fluid aspiration through the tube 158. In alternative embodiments, the tube 158 may also be arranged along a variety of different pathways.
If desired, the tube 158 may have a longitudinally oriented internal feature, such as a monofilament stitch (not shown), that is positioned proximate the point at which the solenoid unit 142 contacts the tube 158 to limit compression of the tube 158. Thus, the solenoid unit 142 may be able to dramatically decrease, but not entirely, stop, fluid aspiration from the internal wound site 12.
Assembly of the infusion unit 14 is relatively simple, and may be performed according to a variety of methods. According to one example, the circuit board 138, the motor 140, and the solenoid unit 142 may be inserted generally along the longitudinal direction 40 into the second portion 58 of the main body 52 of the controller 46 and attached to the second portion 58, to each other, or to some combination thereof. The compressible overlay 144 may be positioned against the contact extension 146, and the compressible overlay 144 and the contact extension 146 may be inserted into the cover 148. The first and second portions 56, 58 of the main body 52 may be aligned and moved together along the longitudinal direction 40, and attached together via screws, integrally formed snaps, rivets, or other known attachment devices.
The rotors 84 may be installed in the rotor carriage 86 and the rotor carriage 86 may then be attached to the exposed spindle of the motor 140. The cap 54 may be attached to the main body 52 to protect the rotor carriage 86 and the blockage sensor 92. The batteries 136 may be inserted into the open compartment, and the battery cover 134 may be attached to the remainder of the second portion 58 of the main body 52 to complete assembly of the controller 46.
The tubes 80, 158 may be coupled to the various ports 72, 74, 76 and to the corresponding reservoirs 66, 156. The first and second reservoirs 66, 156 may be seated in the first cavity and the second cavity 150, respectively, of the first portion 68 of the reservoir retainer 64, in the first and second cavities 152, 154 of the second portion 70 of the reservoir retainer 64, respectively, or in some combination thereof. The ports 72, 74, 76 are installed in the first portion 68, and the tubes 80, 158 are then arranged as shown in
Once the controller 46 and the reservoir module 48 have been assembled, they may easily be coupled together to permit use of the infusion unit 14. According to one assembly method, the cap 54 of the controller 46 is first removed from the main body 52. The reservoir module 48 is then displaced from the controller along the longitudinal direction 40, as illustrated in
The controller 46 and the reservoir module 48 are then in the properly assembled relative configuration shown in
The tube 80 may then be stretched and inserted longitudinally to fit around the rotors 84 retained by the rotor carriage 86. A portion of the tube 80 is inserted between the arcuate wall 90 and the blockage sensor 92. The tube 80 may then be released so that the tube 80 is tightly routed about the rotors 84. The cap 54 may then be re-attached to the main body 52 to enclose the tube 80, rotors 84, rotor carriage 86, and blockage sensor 92.
Once the controller 46 and the reservoir module 48 have been attached together, the proximal ends 22, 28 of the catheters 16, 18 may be attached to the infusion port 72 and the aspiration port 74, respectively. The distal ends 24, 30 of the catheters 16, 18 are positioned in the internal wound site 12 through the point-of-entry 20. The distal ends 24, 30 may advantageously be positioned on opposite sides of the internal wound site 12 to enhance medication flow across the internal wound site 12.
When the controller 46 is activated, the motor 140 drives the pump 82 to draw medication from the first reservoir 156. The medication is drawn through the tube 80 and separated into discrete quantities due to the compression of the tube 80 proximate the rotors 84. The rotor carriage 86 rotates to move each bolus of medication through the tube 80 and out of the infusion unit 14 via the infusion port 72. The medication then moves to the internal wound site 12 via the infusion catheter 16. Fluids may simultaneously be removed from the internal wound site 12 in a similar manner via the interaction of the solenoid unit 142 with the tube 158. The controller 46 may operate according to a variety of schemes, for example, by providing a quantity of medication periodically, by providing medication on demand (within limits), or the like.
The system 10 of
Referring to
As shown, the infusion unit 214 has a controller 46, which may be identical to the controller 46 illustrated in
Referring to
Like the dovetail feature 110 of the previous embodiment, the dovetail feature 110 of the reservoir module 248 is tapered to mate with the dovetail feature 108 of the controller 46 along only one direction. The dovetail feature 110 of the reservoir module 248 has a locking recess like the locking recess 48 of the previous embodiment. Accordingly, the method by which the reservoir module 248 is coupled to the controller 46 may be identical to that used to attach the reservoir module 48 to the controller 46.
The first portion 268 of the reservoir retainer 264 has a first cavity that receives part of the first reservoir 156. Similarly, the second portion 270 of the reservoir retainer 264 has a first cavity 352 that receives the remainder of the first reservoir 156. The first reservoir 156 may be the same as that of the previous embodiment.
The reservoir module 248 may be assembled in a manner similar to that described previously, in connection with the reservoir module 48. However, no aspiration port, second reservoir, or aspiration tube need be installed. The first and second portions 268, 270 are simply moved together along the longitudinal direction 40 and attached together to retain the first reservoir 156. The reservoir module 248 is then ready for use and may be coupled to the controller 46 via application of the method described in connection with the previous embodiment. Use of the infusion unit 214 is also similar to that described previously, in connection with the discussion of the infusion unit 14, except that no aspiration catheter is used, and aspiration is not performed.
Since either of the reservoir modules 48, 248 is capable of mating with the controller 46, the controller 46, reservoir module 48, and reservoir module 248 may form a kit of interchangeable parts that can be used for a variety of pain relief situations. For example, if aspiration is desired, the reservoir module 48 may be coupled to the controller 46 to form the infusion unit 14. If no aspiration is desired, the reservoir module 248 may be coupled to the controller 46 to form the infusion unit 214. The reservoir module 248 provides a lighter, more compact infusion unit 214 for situations in which aspiration is not needed.
The present invention may be embodied in other specific forms without departing from its spirit or essential characteristics. Thus the described embodiments are to be considered in all respects only as illustrative and not restrictive. The scope of the invention is, therefore, indicated by the appended claims rather than by the foregoing description. All changes which come within the meaning and range of equivalency of the claims are to be embraced within their scope.
This application is a divisional of U.S. application Ser. No. 10/909,157, filed Jul. 7, 2004 and entitled MEDICATION INFUSION SYSTEM AND METHOD (Attorney Docket No. MLI-12) which is a continuation-in-part of U.S. application Ser. No. 10/218,106, filed Aug. 12, 2002 and entitled INTEGRATED INFUSION AND ASPIRATION SYSTEM AND METHOD (Attorney's Docket No. 13447.26). The disclosures of the foregoing are incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
Parent | 10909157 | Jul 2004 | US |
Child | 12411047 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10218106 | Aug 2002 | US |
Child | 10909157 | US |